{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:10:00Z","timestamp":1794741000454,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"8099","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,1,29]]},"DOI":"10.1038\/s41586-025-09815-0","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:02:45Z","timestamp":1762185765000},"page":"1273-1281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Independent mechanisms of inflammation and myeloid bias in VEXAS syndrome"],"prefix":"10.1038","volume":"649","author":[{"given":"Varun K.","family":"Narendra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tandrila","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsey J.","family":"Wierciszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Londoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-6338","authenticated-orcid":false,"given":"Joshua K.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Martindale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9661-2221","authenticated-orcid":false,"given":"Michael","family":"Trombetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8375-3328","authenticated-orcid":false,"given":"Yuzuka","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro E.","family":"Casiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"de Stanchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4179-4807","authenticated-orcid":false,"given":"Caleb A.","family":"Lareau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5284-9650","authenticated-orcid":false,"given":"Scott W.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9229-0919","authenticated-orcid":false,"given":"Alexander D.","family":"Gitlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"9815_CR1","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck, D. B. et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N. Engl. J. Med. 383, 2628\u20132638 (2020).","journal-title":"N. Engl. J. Med."},{"key":"9815_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jama.2022.24836","volume":"329","author":"DB Beck","year":"2023","unstructured":"Beck, D. B. et al. Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population. JAMA 329, 318\u2013324 (2023).","journal-title":"JAMA"},{"key":"9815_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjd.20805","volume":"186","author":"S Georgin-Lavialle","year":"2022","unstructured":"Georgin-Lavialle, S. et al. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br. J. Dermatol. 186, 564\u2013574 (2022).","journal-title":"Br. J. Dermatol."},{"key":"9815_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/j.seminhematol.2021.10.003","volume":"58","author":"A Oganesyan","year":"2021","unstructured":"Oganesyan, A., Hakobyan, Y., Terrier, B., Georgin-Lavialle, S. & Mekinian, A. Looking beyond VEXAS: coexistence of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome. Semin. Hematol. 58, 247\u2013253 (2021).","journal-title":"Semin. Hematol."},{"key":"9815_CR5","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","volume":"5","author":"IE Obiorah","year":"2021","unstructured":"Obiorah, I. E. et al. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Adv. 5, 3203\u20133215 (2021).","journal-title":"Blood Adv."},{"key":"9815_CR6","first-page":"3591","volume":"137","author":"PC Grayson","year":"2021","unstructured":"Grayson, P. C., Patel, B. A. & Young, N. S. VEXAS syndrome. Blood 137, 3591\u20133594 (2021).","journal-title":"Blood"},{"key":"9815_CR7","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1182\/blood.2020010177","volume":"137","author":"E Bourbon","year":"2021","unstructured":"Bourbon, E. et al. Therapeutic options in VEXAS syndrome: insights from a retrospective series. Blood 137, 3682\u20133684 (2021).","journal-title":"Blood"},{"key":"9815_CR8","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1182\/blood.2022016985","volume":"140","author":"MA Ferrada","year":"2022","unstructured":"Ferrada, M. A. et al. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood 140, 1496\u20131506 (2022).","journal-title":"Blood"},{"key":"9815_CR9","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1093\/rheumatology\/keab524","volume":"60","author":"M Templ\u00e9","year":"2021","unstructured":"Templ\u00e9, M. et al. Atypical splice-site mutations causing VEXAS syndrome. Rheumatology 60, e435\u2013e437 (2021).","journal-title":"Rheumatology"},{"key":"9815_CR10","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1182\/blood.2020010286","volume":"137","author":"JA Poulter","year":"2021","unstructured":"Poulter, J. A. et al. Novel somatic mutations in UBA1 as a cause of VEXAS syndrome. Blood 137, 3676\u20133681 (2021).","journal-title":"Blood"},{"key":"9815_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2016.07.019","volume":"166","author":"RB Damgaard","year":"2016","unstructured":"Damgaard, R. B. et al. The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity. Cell 166, 1215\u20131230 (2016).","journal-title":"Cell"},{"key":"9815_CR12","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/ni.2457","volume":"13","author":"B Boisson","year":"2012","unstructured":"Boisson, B. et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat. Immunol. 13, 1178\u20131186 (2012).","journal-title":"Nat. Immunol."},{"key":"9815_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-018-0256-2","volume":"559","author":"K Heger","year":"2018","unstructured":"Heger, K. et al. OTULIN limits cell death and inflammation by deubiquitinating LUBAC. Nature 559, 120\u2013124 (2018).","journal-title":"Nature"},{"key":"9815_CR14","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1084\/jem.20141130","volume":"212","author":"B Boisson","year":"2015","unstructured":"Boisson, B. et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J. Exp. Med. 212, 939\u2013951 (2015).","journal-title":"J. Exp. Med."},{"key":"9815_CR15","doi-asserted-by":"publisher","first-page":"10127","DOI":"10.1073\/pnas.1612594113","volume":"113","author":"Q Zhou","year":"2016","unstructured":"Zhou, Q. et al. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc. Natl Acad. Sci. USA 113, 10127\u201310132 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9815_CR16","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1126\/science.aar2641","volume":"361","author":"D Cuchet-Louren\u00e7o","year":"2018","unstructured":"Cuchet-Louren\u00e7o, D. et al. Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation. Science 361, 810\u2013813 (2018).","journal-title":"Science"},{"key":"9815_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.3459","volume":"48","author":"Q Zhou","year":"2016","unstructured":"Zhou, Q. et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat. Genet. 48, 67\u201373 (2016).","journal-title":"Nat. Genet."},{"key":"9815_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41590-024-01817-w","volume":"25","author":"H Oda","year":"2024","unstructured":"Oda, H. et al. Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiency. Nat. Immunol. 25, 764\u2013777 (2024).","journal-title":"Nat. Immunol."},{"key":"9815_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41586-019-1828-5","volume":"577","author":"N Lalaoui","year":"2020","unstructured":"Lalaoui, N. et al. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease. Nature 577, 103\u2013108 (2020).","journal-title":"Nature"},{"key":"9815_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-019-1830-y","volume":"577","author":"P Tao","year":"2020","unstructured":"Tao, P. et al. A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1. Nature 577, 109\u2013114 (2020).","journal-title":"Nature"},{"key":"9815_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.celrep.2014.08.066","volume":"9","author":"N Peltzer","year":"2014","unstructured":"Peltzer, N. et al. HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell Rep. 9, 153\u2013165 (2014).","journal-title":"Cell Rep."},{"key":"9815_CR22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.03464","volume":"3","author":"JA Rickard","year":"2014","unstructured":"Rickard, J. A. et al. TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice. eLife 3, e03464 (2014).","journal-title":"eLife"},{"key":"9815_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature09816","volume":"471","author":"B Gerlach","year":"2011","unstructured":"Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591\u2013596 (2011).","journal-title":"Nature"},{"key":"9815_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton, R. T., Christie, K. A., Whittaker, M. N. & Kleinstiver, B. P. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science 368, 290\u2013296 (2020).","journal-title":"Science"},{"key":"9815_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"9815_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"9815_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"9815_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","volume":"131","author":"E Varfolomeev","year":"2007","unstructured":"Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-\u03baB activation, and TNF\u03b1-dependent apoptosis. Cell 131, 669\u2013681 (2007).","journal-title":"Cell"},{"key":"9815_CR29","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cell.2007.10.037","volume":"131","author":"JE Vince","year":"2007","unstructured":"Vince, J. E. et al. IAP antagonists target cIAP1 to induce TNF\u03b1-dependent apoptosis. Cell 131, 682\u2013693 (2007).","journal-title":"Cell"},{"key":"9815_CR30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.molcel.2008.05.014","volume":"30","author":"MJM Bertrand","year":"2008","unstructured":"Bertrand, M. J. M. et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689\u2013700 (2008).","journal-title":"Mol. Cell"},{"key":"9815_CR31","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/cdd.2013.94","volume":"20","author":"Y Dondelinger","year":"2013","unstructured":"Dondelinger, Y. et al. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1\/2 depletion or TAK1 kinase inhibition. Cell Death Differ. 20, 1381\u20131392 (2013).","journal-title":"Cell Death Differ."},{"key":"9815_CR32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1061","volume":"5","author":"E Meylan","year":"2004","unstructured":"Meylan, E. et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-\u03baB activation. Nat. Immunol. 5, 503\u2013507 (2004).","journal-title":"Nat. Immunol."},{"key":"9815_CR33","doi-asserted-by":"publisher","first-page":"20054","DOI":"10.1073\/pnas.1116302108","volume":"108","author":"S He","year":"2011","unstructured":"He, S., Liang, Y., Shao, F. & Wang, X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl Acad. Sci. USA 108, 20054\u201320059 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9815_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32103-8","volume":"13","author":"Y Tazi","year":"2022","unstructured":"Tazi, Y. et al. Unified classification and risk-stratification in acute myeloid leukemia. Nat. Commun. 13, 4622 (2022).","journal-title":"Nat. Commun."},{"key":"9815_CR35","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","volume":"52","author":"KL Bolton","year":"2020","unstructured":"Bolton, K. L. et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat. Genet. 52, 1219\u20131226 (2020).","journal-title":"Nat. Genet."},{"key":"9815_CR36","unstructured":"Bernard, E. et al. Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid. 1, EVIDoa2200008 (2022)."},{"key":"9815_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09857","volume":"471","author":"WJ Kaiser","year":"2011","unstructured":"Kaiser, W. J. et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368\u2013372 (2011).","journal-title":"Nature"},{"key":"9815_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nature09852","volume":"471","author":"A Oberst","year":"2011","unstructured":"Oberst, A. et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363\u2013367 (2011).","journal-title":"Nature"},{"key":"9815_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.immuni.2016.07.016","volume":"45","author":"S Alvarez-Diaz","year":"2016","unstructured":"Alvarez-Diaz, S. et al. The pseudokinase MLKL and the kinase RIPK3 have distinct roles in autoimmune disease caused by loss of death-receptor-induced apoptosis. Immunity 45, 513\u2013526 (2016).","journal-title":"Immunity"},{"key":"9815_CR40","doi-asserted-by":"publisher","first-page":"31268","DOI":"10.1074\/jbc.M113.462341","volume":"288","author":"WJ Kaiser","year":"2013","unstructured":"Kaiser, W. J. et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J. Biol. Chem. 288, 31268\u201331279 (2013).","journal-title":"J. Biol. Chem."},{"key":"9815_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44811-4","volume":"15","author":"O Kosmider","year":"2024","unstructured":"Kosmider, O. et al. VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation. Nat. Commun. 15, 910 (2024).","journal-title":"Nat. Commun."},{"key":"9815_CR42","doi-asserted-by":"publisher","unstructured":"Ganesan, S. et al. Single-cell genotype-phenotype mapping identifies therapeutic vulnerabilities in VEXAS syndrome. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.05.19.594376 (2024).","DOI":"10.1101\/2024.05.19.594376"},{"key":"9815_CR43","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1021\/jm5017494","volume":"58","author":"AL Smith","year":"2015","unstructured":"Smith, A. L. et al. Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK). J. Med. Chem. 58, 1426\u20131441 (2015).","journal-title":"J. Med. Chem."},{"key":"9815_CR44","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41591-025-03623-9","volume":"31","author":"R Molteni","year":"2025","unstructured":"Molteni, R. et al. Mechanisms of hematopoietic clonal dominance in VEXAS syndrome. Nat. Med. 31, 1911\u20131924 (2025).","journal-title":"Nat. Med."},{"key":"9815_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41586-019-1244-x","volume":"571","author":"AC Wilkinson","year":"2019","unstructured":"Wilkinson, A. C. et al. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature 571, 117\u2013121 (2019).","journal-title":"Nature"},{"key":"9815_CR46","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ncb3346","volume":"18","author":"EM Pietras","year":"2016","unstructured":"Pietras, E. M. et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat. Cell Biol. 18, 607\u2013618 (2016).","journal-title":"Nat. Cell Biol."},{"key":"9815_CR47","doi-asserted-by":"publisher","first-page":"13973","DOI":"10.1073\/pnas.93.24.13973","volume":"93","author":"HB Shu","year":"1996","unstructured":"Shu, H. B., Takeuchi, M. & Goeddel, D. V. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc. Natl Acad. Sci. USA 93, 13973\u201313978 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9815_CR48","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/ni.1638","volume":"9","author":"MA Ermolaeva","year":"2008","unstructured":"Ermolaeva, M. A. et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat. Immunol. 9, 1037\u20131046 (2008).","journal-title":"Nat. Immunol."},{"key":"9815_CR49","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.bbrc.2016.04.141","volume":"474","author":"CH Emmerich","year":"2016","unstructured":"Emmerich, C. H. et al. Lys63\/Met1-hybrid ubiquitin chains are commonly formed during the activation of innate immune signalling. Biochem. Biophys. Res. Commun. 474, 452\u2013461 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9815_CR50","doi-asserted-by":"publisher","first-page":"15247","DOI":"10.1073\/pnas.1314715110","volume":"110","author":"CH Emmerich","year":"2013","unstructured":"Emmerich, C. H. et al. Activation of the canonical IKK complex by K63\/M1-linked hybrid ubiquitin chains. Proc. Natl Acad. Sci. USA 110, 15247\u201315252 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9815_CR51","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.molcel.2009.10.013","volume":"36","author":"TL Haas","year":"2009","unstructured":"Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831\u2013844 (2009).","journal-title":"Mol. Cell"},{"key":"9815_CR52","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cell.2009.03.007","volume":"136","author":"S Rahighi","year":"2009","unstructured":"Rahighi, S. et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell 136, 1098\u20131109 (2009).","journal-title":"Cell"},{"key":"9815_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181\u2013190 (2003).","journal-title":"Cell"},{"key":"9815_CR54","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1128\/MCB.24.4.1464-1469.2004","volume":"24","author":"K Newton","year":"2004","unstructured":"Newton, K., Sun, X. & Dixit, V. M. Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell. Biol. 24, 1464\u20131469 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"9815_CR55","doi-asserted-by":"publisher","first-page":"101160","DOI":"10.1016\/j.xcrm.2023.101160","volume":"4","author":"Z Wu","year":"2023","unstructured":"Wu, Z. et al. Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS. Cell Rep. Med. 4, 101160 (2023).","journal-title":"Cell Rep. Med."},{"key":"9815_CR56","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.aba9304","volume":"374","author":"S Avagyan","year":"2021","unstructured":"Avagyan, S. et al. Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis. Science 374, 768\u2013772 (2021).","journal-title":"Science"},{"key":"9815_CR57","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","volume":"39","author":"JM Murphy","year":"2013","unstructured":"Murphy, J. M. et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443\u2013453 (2013).","journal-title":"Immunity"},{"key":"9815_CR58","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1126\/science.1249361","volume":"343","author":"K Newton","year":"2014","unstructured":"Newton, K. et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343, 1357\u20131360 (2014).","journal-title":"Science"},{"key":"9815_CR59","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1084\/jem.184.4.1397","volume":"184","author":"M Pasparakis","year":"1996","unstructured":"Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397\u20131411 (1996).","journal-title":"J. Exp. Med."},{"key":"9815_CR60","doi-asserted-by":"publisher","first-page":"943","DOI":"10.4049\/jimmunol.160.2.943","volume":"160","author":"JJ Peschon","year":"1998","unstructured":"Peschon, J. J. et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160, 943\u2013952 (1998).","journal-title":"J. Immunol."},{"key":"9815_CR61","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191692","volume":"217","author":"EC Freund","year":"2020","unstructured":"Freund, E. C. et al. Efficient gene knockout in primary human and murine myeloid cells by non-viral delivery of CRISPR-Cas9. J. Exp. Med. 217, e20191692 (2020).","journal-title":"J. Exp. Med."},{"key":"9815_CR62","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1261\/rna.069286.118","volume":"25","author":"Z Trepotec","year":"2019","unstructured":"Trepotec, Z., Geiger, J., Plank, C., Aneja, M. K. & Rudolph, C. Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life. RNA 25, 507\u2013518 (2019).","journal-title":"RNA"},{"key":"9815_CR63","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ymthe.2018.12.011","volume":"27","author":"AG Orlandini von Niessen","year":"2019","unstructured":"Orlandini von Niessen, A. G. et al. Improving mRNA-based therapeutic gene delivery by expression-augmenting 3\u2019 UTRs identified by cellular library screening. Mol. Ther. 27, 824\u2013836 (2019).","journal-title":"Mol. Ther."},{"key":"9815_CR64","doi-asserted-by":"publisher","first-page":"W171","DOI":"10.1093\/nar\/gkz365","volume":"47","author":"K Labun","year":"2019","unstructured":"Labun, K. et al. CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res. 47, W171\u2013W174 (2019).","journal-title":"Nucleic Acids Res."},{"key":"9815_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).","journal-title":"Genome Biol."},{"key":"9815_CR66","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"9815_CR67","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09815-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09815-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09815-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:05:18Z","timestamp":1769605518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09815-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":67,"journal-issue":{"issue":"8099","published-print":{"date-parts":[[2026,1,29]]}},"alternative-id":["9815"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09815-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.D.G. is a consultant for Genentech. While not directly related to this manuscript, S.W.L. declares outside consultancy and equity for Oric Pharmaceuticals, Blueprint Medicines, Mirimus, Senecea Therapeutics, Faeth Therapeutics and PMV Pharmaceuticals; and outside consultancy (no equity) for Fate Therapeutics. C.A.L. is a consultant to Cartography Biosciences. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}